89 related articles for article (PubMed ID: 8638367)
1. Treatment of subclinical intraurethral human papilloma virus infection with interferon alfa-2b.
Levine LA; Elterman L; Rukstalis DB
Urology; 1996 Apr; 47(4):553-7. PubMed ID: 8638367
[TBL] [Abstract][Full Text] [Related]
2. Intraurethral fluorouracil and lidocaine for intraurethral condyloma acuminata.
Gammon DC; Reed KA; Patel M; Balaji KC
Am J Health Syst Pharm; 2008 Oct; 65(19):1830-3. PubMed ID: 18796424
[TBL] [Abstract][Full Text] [Related]
3. Urethroscopy and urethral cytology in men with external genital condyloma.
Fralick RA; Malek RS; Goellner JR; Hyland KM
Urology; 1994 Mar; 43(3):361-4. PubMed ID: 8134991
[TBL] [Abstract][Full Text] [Related]
4. Interferon alfa-2b for treatment of subclinical intraurethral human papilloma virus infection.
Harrison RH
Urology; 1997 Aug; 50(2):317. PubMed ID: 9255317
[No Abstract] [Full Text] [Related]
5. Treatment of intraurethral condylomata acuminata with surgery and cidofovir instillations in two immunocompromised patients and review of the literature.
Florin HJ; Snoeck R; Van Cleynenbreugel B; Albersen M
Antiviral Res; 2018 Oct; 158():238-243. PubMed ID: 30153444
[TBL] [Abstract][Full Text] [Related]
6. Intraurethral condylomata acuminata associated with genital piercings.
Takahashi S; Hirano Y; Kawamura T; Homma Y
Int J STD AIDS; 2013 Jan; 24(1):67-9. PubMed ID: 23512508
[TBL] [Abstract][Full Text] [Related]
7. Holmium:YAG laser ablation combined intraurethral fluorouracil perfusion as treatment option for intraurethral Condyloma acuminata in men.
Ge CG; Jiang J; Jiang Q; Liu C; Hu ZL; Liang PH; Zhang WL
Minerva Urol Nefrol; 2014 Mar; 66(1):77-81. PubMed ID: 24721943
[TBL] [Abstract][Full Text] [Related]
8. Cryosurgery plus adjuvant systemic alpha2-interferon for HPV-associated lesions.
Scala M; Bonelli G; Gipponi M; Margarino G; Muzza A
Anticancer Res; 2002; 22(2B):1171-6. PubMed ID: 12168920
[TBL] [Abstract][Full Text] [Related]
9. MVA E2 recombinant vaccine in the treatment of human papillomavirus infection in men presenting intraurethral flat condyloma: a phase I/II study.
Albarran Y Carvajal A; de la Garza A; Cruz Quiroz BJ; Vazquez Zea E; Díaz Estrada I; Mendez Fuentez E; López Contreras M; Andrade-Manzano A; Padilla S; Varela AR; Rosales R
BioDrugs; 2007; 21(1):47-59. PubMed ID: 17263589
[TBL] [Abstract][Full Text] [Related]
10. [Effects of human papilloma virus types on course of juvenile respiratory papillomatosis and effectiveness of interferon therapy in children].
Nurmukhametov RKh; Onufrieva EK; Soldatskiĭ IuL; Brodskiĭ MIu
Vestn Otorinolaringol; 2000; (2):37-40. PubMed ID: 10771610
[TBL] [Abstract][Full Text] [Related]
11. Developmental factors of urethral human papillomavirus lesions: correlation with circumcision.
Aynaud O; Piron D; Bijaoui G; Casanova JM
BJU Int; 1999 Jul; 84(1):57-60. PubMed ID: 10444125
[TBL] [Abstract][Full Text] [Related]
12. Urethral cytology of Cytobrush specimens. A new technique for detecting subclinical human papillomavirus infection in men.
Cecchini S; Cipparrone I; Confortini M; Scuderi A; Meini L; Piazzesi G
Acta Cytol; 1988; 32(3):314-7. PubMed ID: 2837034
[TBL] [Abstract][Full Text] [Related]
13. [Intralesional therapy using recombinant interferon alpha 2 B in lesions of the uterine cervix caused by human papilloma virus].
Germano A; Stellato G; Lombardo G; de Simone A; Semenza G
Minerva Ginecol; 1989 Jun; 41(6):277-81. PubMed ID: 2549455
[TBL] [Abstract][Full Text] [Related]
14. Long-term followup of subclinical human papillomavirus infection treated with the carbon dioxide laser and intraurethral 5-fluorouracil: a treatment protocol.
Carpiniello VL; Schoenberg M; Malloy TR
J Urol; 1990 Apr; 143(4):726-8. PubMed ID: 2156087
[TBL] [Abstract][Full Text] [Related]
15. Topic and systemic administration of natural alfa interferon in the treatment of female and male HPV genital infections.
Stentella P; Frega A; Di Renzi F; Palazzetti PL; Pachì A
Clin Exp Obstet Gynecol; 1996; 23(1):29-36. PubMed ID: 8653931
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic phase antibody response to the human papillomavirus type 16 E2 protein is associated with successful treatment of genital HPV lesions with systemic interferon alpha-2b.
Stellato G; Paavonen J; Nieminen P; Hibma M; Vilja P; Lehtinen M
Clin Diagn Virol; 1997 Feb; 7(3):167-72. PubMed ID: 9126686
[TBL] [Abstract][Full Text] [Related]
17. Persistence of human papillomavirus type 6e in adult multiple laryngeal papilloma and the counterpart false cord of an interferon-treated patient.
Ogura H; Watanabe S; Fukushima K; Baba Y; Masuda Y; Fujiwara T; Yabe Y
Jpn J Clin Oncol; 1993 Apr; 23(2):130-3. PubMed ID: 8390585
[TBL] [Abstract][Full Text] [Related]
18. A new mode of treatment of human papilloma virus associated anogenital lesions using a nonsteroid estrogen analogue.
Schön HJ; Grgurin M; Szekeres T; Schurz B
Wien Klin Wochenschr; 1996; 108(2):45-7. PubMed ID: 8835432
[TBL] [Abstract][Full Text] [Related]
19. [Human papillomavirus-DNA in laryngeal papilloma detected by nucleic acid hybridization and the clinical treatment].
Liu DJ
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1993; 28(6):358-9, 382. PubMed ID: 8031590
[TBL] [Abstract][Full Text] [Related]
20. Preliminary note on the use of interferon alpha by peroral route in HPV lesions.
Montevecchi L; Caprio G; Vecchione A
Clin Ter; 2000; 151(1 Suppl 1):29-34. PubMed ID: 10876964
[No Abstract] [Full Text] [Related]
[Next] [New Search]
